Table 1 Baseline characteristics of the breast cancer patients
Parameters | Treatment 1 | Treatment 2 | Treatment 3 | p-value |
|---|---|---|---|---|
N | 56 | 39 | 31 | |
BMI, mean (SD) | 31.648214 (7.9894019) | 31.130769 (6.8315119) | 33.212903 (8.8297883) | 0.53 |
Hs-CRP, median (IQR) | 6.935 (2.295–12.62) | 6.53 (2.98–13.29) | 5.44 (2.22–12.41) | 0.97 |
phosphate, median (IQR) | 1.19 (1.09–1.295) | 1.19 (1.03–1.32) | 1.22 (1.12–1.31) | 0.81 |
Calcium, mean (SD) | 2.3473214 (0.09290251) | 2.324359 (0.12069524) | 2.356129 (0.09054198) | 0.39 |
Phosphate, median (IQR) | 4.9 (3.65–6.65) | 5.4 (4.2–7.9) | 5 (3.4–7.5) | 0.23 |
Ferritin, median (IQR) | 87 (34–145) | 58 (35–137) | 86 (34–156) | 0.75 |
Homocysteine, median (IQR) | 11.25 (9.7- 13.35) | 11.6 (10- 15.3) | 10.5 (9.2–14.1) | 0.66 |
Total Body Fat, median (IQR) | 48.75 (42- 53.3) | 46 (43.8–52.2) | 47.8 (43.5–51.5) | 0.76 |
Hip Circumference, mean (SD) | 111.86607 (16.88046) | 111.11538 (14.125128) | 119.91935 (14.208036) | 0.035 |